Patterns of Ventricular Remodeling After Myocardial Infarction. Clues Toward Linkage Between Mechanism and Morbidity**Editorials published in JACC: Cardiovascular Imaging reflect the views of the authors and do not necessarily represent the views of JACC: Cardiovascular Imaging or the American College of Cardiology.

JACC: Cardiovascular Imaging

Volumn 1, Issue 5, 2008, Pages 592-594

  Konstam, Marvin A ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

cardiovascular risk; echocardiography; hypertension; myocardial infarction; ventricular remodeling

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN II; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN; TUMOR NECROSIS FACTOR ALPHA;

ECHOCARDIOGRAPHY; EDITORIAL; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RESUSCITATION; STROKE;

CARDIOVASCULAR DISEASES; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 51749111445     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2008.07.005     Document Type: Editorial

References (12)

1. Erlebacher J.A., Weiss J.L., Eaton L.W., et al. Late effects of acute infarct dilation on heart size: a two-dimensional echocardiographic study. Am J Cardiol 49 (1982) 1120-1126
2. Pfeffer M.A., and Pfeffer J.M. Ventricular enlargement and reduced survival after myocardial infarction. Circulation 75 (1987) IV93-IV97
3. St John Sutton M., Pfeffer M.A., Plappert T., et al. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril. Circulation 89 (1994) 68-75
4. White H.D., Norris R.M., Brown M.A., et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
5. Konstam M.A., Udelson J.E., Anand I.s., and Cohn J.N. Ventricular remodeling in heart failure: a credible surrogate endpoint. J Card Failure 9 (2003) 350-353
6. Vakili B.A., Okin P.M., and Devereux R.B. Prognostic implications of left ventricular hypertrophy. Am Heart J 141 (2001) 334-341
7. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
8. Verma A., Meris A., Skali H., et al. Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) echocardiographic study. J Am Coll Cardiol Img 1 (2008) 582-591
9. Konstam M.A. Natriuretic peptides and cardiovascular events: more than a stretch. JAMA 297 (2007) 212-214
10. Harada M., Saito Y., Kuwahara K., et al. Interaction of myocytes and nonmyocytes is necessary for mechanical stretch to induce ANP/BNP production in cardiocyte culture. J Cardiovasc Pharmacol 31 (1998) S357-S359
11. Tsuruda T., Boerrigter G., Huntley B.K., et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases. Circ Res 91 (2002) 1127-1134
12. Konstam M.A. "Systolic and diastolic dysfunction" in heart failure?. Time for a new paradigm. J Cardiac Fail 9 (2003) 1-3